(Q33496872)

27 July 2017

title

Clinical, immunological, and pathological consequences of Fas-deficient conditions (English)

1 reference

27 July 2017

1 reference

A Fischer

0 references

Frédéric Rieux-Laucat

F Rieux-Laucat

0 references

F Le Deist

1 reference

27 July 2017

J F Emile

1 reference

27 July 2017

M Benkerrou

1 reference

27 July 2017

I Roberts

1 reference

27 July 2017

N Brousse

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

27 July 2017

1 reference

27 July 2017

volume

348

1 reference

27 July 2017

issue

9029

1 reference

27 July 2017

page(s)

719-723

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

27 July 2017

1 reference

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Fas ligand mediates activation-induced cell death in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Normal T cell receptor Vβ usage in a primary immunodeficiency associated with HLA class II deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902293-3

7 January 2021

10.1016/S0140-6736(96)02293-3

Identifiers

DOI

1 reference

27 July 2017

1 reference